{"actionType":"INHIBITOR","mechanismOfAction":"Dipeptidyl peptidase IV inhibitor","chemblIds":["CHEMBL142703"],"targetName":"Dipeptidyl peptidase IV","targetType":"single protein","targets":["ENSG00000197635"],"references":[{"source":"PubMed","ids":["15886245"],"urls":["http://europepmc.org/abstract/MED/15886245"]},{"source":"Other","ids":["http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000771/human_med_000803.jsp&mid=WC0b01ac058001d124"],"urls":["http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000771/human_med_000803.jsp&mid=WC0b01ac058001d124"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Adrenergic receptor alpha-2 antagonist","chemblIds":["CHEMBL1255582"],"targetName":"Adrenergic receptor alpha-2","targetType":"protein family","targets":["ENSG00000150594","ENSG00000184160","ENSG00000274286"],"references":[{"source":"PubMed","ids":["12889076"],"urls":["https://pubmed.ncbi.nlm.nih.gov/12889076/"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial penicillin-binding protein inhibitor","chemblIds":["CHEMBL1605"],"targetName":"Bacterial penicillin-binding protein","targetType":"protein family","targets":[],"references":[{"source":"PubMed","ids":["2120175"],"urls":["http://europepmc.org/abstract/MED/2120175"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Hepatitis A virus cellular receptor 2 inhibitor","chemblIds":["CHEMBL4298123"],"targetName":"Hepatitis A virus cellular receptor 2","targetType":"single protein","targets":["ENSG00000135077"],"references":[{"source":"Other","ids":["https://www.gsk.com/en-gb/research-and-development/our-pipeline/","http://www.anaptysbio.com/wp-content/uploads/Tim3-EORTC-poster-final.pdf"],"urls":["https://www.gsk.com/en-gb/research-and-development/our-pipeline/","http://www.anaptysbio.com/wp-content/uploads/Tim3-EORTC-poster-final.pdf"]},{"source":"PubMed","ids":["32601081"],"urls":["http://europepmc.org/abstract/MED/32601081"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Endothelin receptor ET-A antagonist","chemblIds":["CHEMBL23261"],"targetName":"Endothelin receptor ET-A","targetType":"single protein","targets":["ENSG00000151617"],"references":[{"source":"PubMed","ids":["20660536","20660536"],"urls":["http://europepmc.org/abstract/MED/20660536","http://europepmc.org/abstract/MED/20660536"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Ribosomal protein S6 kinase (P70S6K) inhibitor","chemblIds":["CHEMBL3544935"],"targetName":"Ribosomal protein S6 kinase (P70S6K)","targetType":"protein complex","targets":["ENSG00000175634","ENSG00000108443"],"references":[{"source":"ClinicalTrials","ids":["NCT00460278","NCT00460278"],"urls":["https://www.clinicaltrials.gov/ct2/show/NCT00460278","https://www.clinicaltrials.gov/ct2/show/NCT00460278"]},{"source":"PubMed","ids":["13891463","13891463"],"urls":["http://europepmc.org/abstract/MED/13891463","http://europepmc.org/abstract/MED/13891463"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Cyclooxygenase inhibitor","chemblIds":["CHEMBL341812"],"targetName":"Cyclooxygenase","targetType":"protein family","targets":["ENSG00000073756","ENSG00000095303"],"references":[{"source":"PubMed","ids":["14261081","9061203"],"urls":["http://europepmc.org/abstract/MED/14261081","http://europepmc.org/abstract/MED/9061203"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial 70S ribosome inhibitor","chemblIds":["CHEMBL3989568","CHEMBL1517"],"targetName":"Bacterial 70S ribosome","targetType":"protein nucleic-acid complex","targets":[],"references":[{"source":"KEGG","ids":["D01596"],"urls":["http://www.kegg.jp/dbget-bin/www_bget?dr:D01596"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tumor necrosis factor ligand superfamily member 12 inhibitor","chemblIds":["CHEMBL2109600"],"targetName":"Tumor necrosis factor ligand superfamily member 12","targetType":"single protein","targets":["ENSG00000239697"],"references":[{"source":"PubMed","ids":["23334208","25388164"],"urls":["http://europepmc.org/abstract/MED/23334208","http://europepmc.org/abstract/MED/25388164"]},{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=703243"],"urls":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=703243"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"MAP kinase p38 alpha inhibitor","chemblIds":["CHEMBL1088750"],"targetName":"MAP kinase p38 alpha","targetType":"single protein","targets":["ENSG00000112062"],"references":[{"source":"Other","ids":["http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-797/"],"urls":["http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-797/"]},{"source":"PubMed","ids":["22773734"],"urls":["http://europepmc.org/abstract/MED/22773734"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Mu opioid receptor agonist","chemblIds":["CHEMBL1200817","CHEMBL1514"],"targetName":"Mu opioid receptor","targetType":"single protein","targets":["ENSG00000112038"],"references":[{"source":"PubMed","ids":["9707384"],"urls":["http://europepmc.org/abstract/MED/9707384"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Neuronal acetylcholine receptor protein alpha-7 subunit agonist","chemblIds":["CHEMBL3707316"],"targetName":"Neuronal acetylcholine receptor protein alpha-7 subunit","targetType":"single protein","targets":["ENSG00000175344"],"references":[{"source":"Other","ids":["http://neuroderm.com/cognition-nd0801/","http://slideplayer.com/slide/4968214/"],"urls":["http://neuroderm.com/cognition-nd0801/","http://slideplayer.com/slide/4968214/"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Fibroblast growth factor receptor 2 inhibitor","chemblIds":["CHEMBL2220486"],"targetName":"Fibroblast growth factor receptor 2","targetType":"single protein","targets":["ENSG00000066468"],"references":[{"source":"PubMed","ids":["21212416","22304225","21212416","22304225","21212416","22304225"],"urls":["http://europepmc.org/abstract/MED/21212416","http://europepmc.org/abstract/MED/22304225","http://europepmc.org/abstract/MED/21212416","http://europepmc.org/abstract/MED/22304225","http://europepmc.org/abstract/MED/21212416","http://europepmc.org/abstract/MED/22304225"]},{"source":"Other","ids":["http://bit.ly/1ZGqyT3","http://bit.ly/1ZGqyT3","http://bit.ly/1ZGqyT3"],"urls":["http://bit.ly/1ZGqyT3","http://bit.ly/1ZGqyT3","http://bit.ly/1ZGqyT3"]}]}
{"actionType":"PARTIAL AGONIST","mechanismOfAction":"Beta-1 adrenergic receptor partial agonist","chemblIds":["CHEMBL75753"],"targetName":"Beta-1 adrenergic receptor","targetType":"single protein","targets":["ENSG00000043591"],"references":[{"source":"PubMed","ids":["21878527","28746336","2904884"],"urls":["http://europepmc.org/abstract/MED/21878527","http://europepmc.org/abstract/MED/28746336","http://europepmc.org/abstract/MED/2904884"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Synaptic vesicular amine transporter inhibitor","chemblIds":["CHEMBL1200782","CHEMBL612"],"targetName":"Synaptic vesicular amine transporter","targetType":"single protein","targets":["ENSG00000165646"],"references":[{"source":"PubMed","ids":["16122767","19244097","7869099","17239355","19727679","15955613","7751968"],"urls":["http://europepmc.org/abstract/MED/16122767","http://europepmc.org/abstract/MED/19244097","http://europepmc.org/abstract/MED/7869099","http://europepmc.org/abstract/MED/17239355","http://europepmc.org/abstract/MED/19727679","http://europepmc.org/abstract/MED/15955613","http://europepmc.org/abstract/MED/7751968"]}]}
{"actionType":"CHELATING AGENT","mechanismOfAction":"Lead chelating agent","chemblIds":["CHEMBL1201073"],"references":[{"source":"FDA","ids":["label/2007/019998s013lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/019998s013lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"C-X-C chemokine receptor type 4 inhibitor","chemblIds":["CHEMBL3039543"],"targetName":"C-X-C chemokine receptor type 4","targetType":"single protein","targets":["ENSG00000121966"],"references":[{"source":"PMC","ids":["PMC4823073"],"urls":["http://europepmc.org/articles/PMC4823073"]},{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=673715"],"urls":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=673715"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Proto-oncogene Mas agonist","chemblIds":["CHEMBL3545347"],"targetName":"Proto-oncogene Mas","targetType":"single protein","targets":["ENSG00000130368"],"references":[{"source":"PubMed","ids":["12829792"],"urls":["http://europepmc.org/abstract/MED/12829792"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"B-lymphocyte antigen CD19 binding agent","chemblIds":["CHEMBL4298047"],"targetName":"B-lymphocyte antigen CD19","targetType":"single protein","targets":["ENSG00000177455"],"references":[{"source":"FDA","ids":["label/2020/761163s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761163s000lbl.pdf"]}]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL2109085"],"references":[]}
{"actionType":"AGONIST","mechanismOfAction":"Thrombopoietin receptor agonist","chemblIds":["CHEMBL2107831"],"targetName":"Thrombopoietin receptor","targetType":"single protein","targets":["ENSG00000117400"],"references":[{"source":"FDA","ids":["label/2018/210923s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210923s000lbl.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Histamine H1 receptor antagonist","chemblIds":["CHEMBL1200638","CHEMBL1201287"],"targetName":"Histamine H1 receptor","targetType":"single protein","targets":["ENSG00000196639"],"references":[{"source":"PubMed","ids":["19085565"],"urls":["http://europepmc.org/abstract/MED/19085565"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Metalloproteinase inhibitor","chemblIds":["CHEMBL2205807"],"references":[{"source":"PubMed","ids":["17892616","23185497","28082644","17892616","23185497","28082644","17892616","23185497","28082644","17892616","23185497","28082644"],"urls":["http://europepmc.org/abstract/MED/17892616","http://europepmc.org/abstract/MED/23185497","http://europepmc.org/abstract/MED/28082644","http://europepmc.org/abstract/MED/17892616","http://europepmc.org/abstract/MED/23185497","http://europepmc.org/abstract/MED/28082644","http://europepmc.org/abstract/MED/17892616","http://europepmc.org/abstract/MED/23185497","http://europepmc.org/abstract/MED/28082644","http://europepmc.org/abstract/MED/17892616","http://europepmc.org/abstract/MED/23185497","http://europepmc.org/abstract/MED/28082644"]},{"source":"FDA","ids":["label/2020/206966lbl.pdf","label/2020/206966lbl.pdf","label/2020/206966lbl.pdf","label/2020/206966lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206966lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206966lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206966lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206966lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Interleukin-13 inhibitor","chemblIds":["CHEMBL2109464"],"targetName":"Interleukin-13","targetType":"single protein","targets":["ENSG00000169194"],"references":[{"source":"PubMed","ids":["26124191"],"urls":["http://europepmc.org/abstract/MED/26124191"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Neurotrophic tyrosine kinase receptor type 2 inhibitor","chemblIds":["CHEMBL3545179"],"targetName":"Neurotrophic tyrosine kinase receptor type 2","targetType":"single protein","targets":["ENSG00000148053"],"references":[{"source":"PubMed","ids":["23027130","25054037","23027130","25054037","23027130","25054037"],"urls":["http://europepmc.org/abstract/MED/23027130","http://europepmc.org/abstract/MED/25054037","http://europepmc.org/abstract/MED/23027130","http://europepmc.org/abstract/MED/25054037","http://europepmc.org/abstract/MED/23027130","http://europepmc.org/abstract/MED/25054037"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Orexin receptor 2 antagonist","chemblIds":["CHEMBL3545367"],"targetName":"Orexin receptor 2","targetType":"single protein","targets":["ENSG00000137252"],"references":[{"source":"Other","ids":["http://www.eisai.com/pdf/eir/erepo/epipeline.pdf","http://www.eisai.com/pdf/eir/erepo/epipeline.pdf"],"urls":["http://www.eisai.com/pdf/eir/erepo/epipeline.pdf","http://www.eisai.com/pdf/eir/erepo/epipeline.pdf"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Beta-2 adrenergic receptor agonist","chemblIds":["CHEMBL1082607","CHEMBL1263"],"targetName":"Beta-2 adrenergic receptor","targetType":"single protein","targets":["ENSG00000169252"],"references":[{"source":"DailyMed","ids":["setid=f53cb2d5-3267-401e-9393-dff8357830dd#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f53cb2d5-3267-401e-9393-dff8357830dd#nlm34090-1"]}]}
{"mechanismOfAction":"Reducing agent","chemblIds":["CHEMBL1314"],"references":[{"source":"DailyMed","ids":["setid=494a714e-923c-cd57-df6c-12886afb265a#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=494a714e-923c-cd57-df6c-12886afb265a#nlm34090-1"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serotonin transporter inhibitor","chemblIds":["CHEMBL1409","CHEMBL814"],"targetName":"Serotonin transporter","targetType":"single protein","targets":["ENSG00000108576"],"references":[{"source":"Wikipedia","ids":["Fluvoxamine"],"urls":["http://en.wikipedia.org/wiki/Fluvoxamine"]},{"source":"FDA","ids":["label/2012/021519s003lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021519s003lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Topoisomerase IV","chemblIds":["CHEMBL8"],"targetName":"Topoisomerase IV","targetType":"protein complex","targets":[],"references":[{"source":"FDA","ids":["label/2009/021918lbl.pdf","label/2019/021473s040lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021918lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021473s040lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Carbonic anhydrase I inhibitor","chemblIds":["CHEMBL19"],"targetName":"Carbonic anhydrase I","targetType":"single protein","targets":["ENSG00000133742"],"references":[{"source":"PubMed","ids":["18336310","18336310","18336310","18336310"],"urls":["http://europepmc.org/abstract/MED/18336310","http://europepmc.org/abstract/MED/18336310","http://europepmc.org/abstract/MED/18336310","http://europepmc.org/abstract/MED/18336310"]},{"source":"DailyMed","ids":["setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207","setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207","setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207","setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207"]}]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL1201603"],"references":[{"source":"PubMed","ids":["7192510"],"urls":["http://europepmc.org/abstract/MED/7192510"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Muscle-type nicotinic acetylcholine receptor antagonist","chemblIds":["CHEMBL1200549","CHEMBL1201352"],"targetName":"Muscle-type nicotinic acetylcholine receptor","targetType":"protein complex group","targets":["ENSG00000138435","ENSG00000196811","ENSG00000170175","ENSG00000135902","ENSG00000108556"],"references":[{"source":"KEGG","ids":["D05703"],"urls":["http://www.kegg.jp/dbget-bin/www_bget?dr:D05703"]},{"source":"FDA","ids":["label/2010/020984s003lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020984s003lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Glutathione reductase inhibitor","chemblIds":["CHEMBL513"],"targetName":"Glutathione reductase","targetType":"single protein","targets":["ENSG00000104687"],"references":[{"source":"PubMed","ids":["15321730"],"urls":["http://europepmc.org/abstract/MED/15321730"]},{"source":"FDA","ids":["label/2013/017422s046lbl.pdf","label/2013/017422s046lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017422s046lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017422s046lbl.pdf"]}]}
{"actionType":"AGONIST","mechanismOfAction":"GABA-A receptor; anion channel agonist","chemblIds":["CHEMBL979"],"targetName":"GABA-A receptor; anion channel","targetType":"protein complex group","targets":["ENSG00000022355","ENSG00000145864","ENSG00000113327","ENSG00000166206","ENSG00000109158","ENSG00000182256","ENSG00000268089","ENSG00000011677","ENSG00000094755","ENSG00000187730","ENSG00000163285","ENSG00000163288","ENSG00000102287","ENSG00000151834","ENSG00000186297","ENSG00000145863"],"references":[{"source":"Wikipedia","ids":["Meprobamate"],"urls":["http://en.wikipedia.org/wiki/Meprobamate"]},{"source":"PubMed","ids":["9067327"],"urls":["http://europepmc.org/abstract/MED/9067327"]}]}
{"actionType":"POSITIVE ALLOSTERIC MODULATOR","mechanismOfAction":"GABA receptor alpha-3 subunit positive allosteric modulator","chemblIds":["CHEMBL1783256"],"targetName":"GABA receptor alpha-3 subunit","targetType":"single protein","targets":["ENSG00000011677"],"references":[{"source":"PubMed","ids":["25493397","25493397"],"urls":["http://europepmc.org/abstract/MED/25493397","http://europepmc.org/abstract/MED/25493397"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Monoamine oxidase A inhibitor","chemblIds":["CHEMBL86304"],"targetName":"Monoamine oxidase A","targetType":"single protein","targets":["ENSG00000189221"],"references":[{"source":"Other","ids":["https://bnf.nice.org.uk/drug/moclobemide.html"],"urls":["https://bnf.nice.org.uk/drug/moclobemide.html"]}]}
{"actionType":"BLOCKER","mechanismOfAction":"Voltage-gated T-type calcium channel blocker","chemblIds":["CHEMBL1534525","CHEMBL45816"],"targetName":"Voltage-gated T-type calcium channel","targetType":"protein family","targets":["ENSG00000196557","ENSG00000006283","ENSG00000100346"],"references":[{"source":"PubMed","ids":["9375939"],"urls":["http://europepmc.org/abstract/MED/9375939"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA polymerase/reverse transcriptase inhibitor","chemblIds":["CHEMBL1652128"],"targetName":"DNA polymerase/reverse transcriptase","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["19223649","19223649"],"urls":["https://pubmed.ncbi.nlm.nih.gov/19223649/","https://pubmed.ncbi.nlm.nih.gov/19223649/"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Insulin receptor agonist","chemblIds":["CHEMBL1201664"],"targetName":"Insulin receptor","targetType":"single protein","targets":["ENSG00000171105"],"references":[{"source":"DailyMed","ids":["setid=3a1e73a2-3009-40d0-876c-b4cb2be56fc5"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a1e73a2-3009-40d0-876c-b4cb2be56fc5"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Cyclin-dependent kinase 2 inhibitor","chemblIds":["CHEMBL384304"],"targetName":"Cyclin-dependent kinase 2","targetType":"single protein","targets":["ENSG00000123374"],"references":[]}
{"actionType":"INHIBITOR","mechanismOfAction":"GMP synthase [glutamine-hydrolyzing] inhibitor","chemblIds":["CHEMBL245019"],"targetName":"GMP synthase [glutamine-hydrolyzing]","targetType":"single protein","targets":["ENSG00000163655"],"references":[{"source":"PubMed","ids":["11896886","11896886"],"urls":["https://pubmed.ncbi.nlm.nih.gov/11896886/","https://pubmed.ncbi.nlm.nih.gov/11896886/"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Beta-1 adrenergic receptor antagonist","chemblIds":["CHEMBL2356097","CHEMBL13"],"targetName":"Beta-1 adrenergic receptor","targetType":"single protein","targets":["ENSG00000043591"],"references":[{"source":"DailyMed","ids":["setid=31d8610a-ab22-49e5-a762-6b08244ee93a"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31d8610a-ab22-49e5-a762-6b08244ee93a"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial 70S ribosome inhibitor","chemblIds":["CHEMBL221886"],"targetName":"Bacterial 70S ribosome","targetType":"protein nucleic-acid complex","targets":[],"references":[{"source":"PubMed","ids":["30113694"],"urls":["https://pubmed.ncbi.nlm.nih.gov/30113694/"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase Chk1 inhibitor","chemblIds":["CHEMBL3545377"],"targetName":"Serine/threonine-protein kinase Chk1","targetType":"single protein","targets":["ENSG00000149554"],"references":[{"source":"Other","ids":["http://www.lillyoncologypipeline.com/chk1-inhibitor.aspx"],"urls":["http://www.lillyoncologypipeline.com/chk1-inhibitor.aspx"]},{"source":"PubMed","ids":["5828916"],"urls":["http://europepmc.org/abstract/MED/5828916"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Poly [ADP-ribose] polymerase-1 inhibitor","chemblIds":["CHEMBL3137318","CHEMBL3137320"],"targetName":"Poly [ADP-ribose] polymerase-1","targetType":"single protein","targets":["ENSG00000143799"],"references":[{"source":"PubMed","ids":["23881923","23881923"],"urls":["http://europepmc.org/abstract/MED/23881923","http://europepmc.org/abstract/MED/23881923"]}]}
{"actionType":"SEQUESTERING AGENT","mechanismOfAction":"Bile acids sequestering agent","chemblIds":["CHEMBL1201473"],"references":[{"source":"DailyMed","ids":["setid=4a06d3b2-7229-4398-baba-5d0a72f63821#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a06d3b2-7229-4398-baba-5d0a72f63821#nlm34090-1"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"T-cell immunoreceptor with Ig and ITIM domains inhibitor","chemblIds":["CHEMBL4650473"],"targetName":"T-cell immunoreceptor with Ig and ITIM domains","targetType":"single protein","targets":["ENSG00000181847"],"references":[{"source":"ClinicalTrials","ids":["NCT04672369"],"urls":["https://clinicaltrials.gov/ct2/show/NCT04672369"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Delta(24)-sterol reductase inhibitor","chemblIds":["CHEMBL187709"],"targetName":"Delta(24)-sterol reductase","targetType":"single protein","targets":["ENSG00000116133"],"references":[{"source":"Wikipedia","ids":["Triparanol"],"urls":["https://en.wikipedia.org/wiki/Triparanol"]},{"source":"PubMed","ids":["16695861"],"urls":["http://europepmc.org/abstract/MED/16695861"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Transforming growth factor beta-3 inhibitor","chemblIds":["CHEMBL1743022"],"targetName":"Transforming growth factor beta-3","targetType":"single protein","targets":["ENSG00000119699"],"references":[{"source":"PubMed","ids":["21368745","21368745","21368745"],"urls":["http://europepmc.org/abstract/MED/21368745","http://europepmc.org/abstract/MED/21368745","http://europepmc.org/abstract/MED/21368745"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"PI3-kinase p110-gamma subunit inhibitor","chemblIds":["CHEMBL4297584"],"targetName":"PI3-kinase p110-gamma subunit","targetType":"single protein","targets":["ENSG00000105851"],"references":[{"source":"ClinicalTrials","ids":["NCT03711578","NCT03711578"],"urls":["https://www.clinicaltrials.gov/ct2/show/NCT03711578","https://www.clinicaltrials.gov/ct2/show/NCT03711578"]},{"source":"PubMed","ids":["32824175","32824175"],"urls":["http://europepmc.org/abstract/MED/32824175","http://europepmc.org/abstract/MED/32824175"]}]}
{"actionType":"BLOCKER","mechanismOfAction":"Voltage-gated L-type calcium channel blocker","chemblIds":["CHEMBL1237132"],"targetName":"Voltage-gated L-type calcium channel","targetType":"protein family","targets":["ENSG00000151067","ENSG00000081248","ENSG00000157388","ENSG00000102001"],"references":[{"source":"DailyMed","ids":["setid=095081a0-1398-11dc-82e1-0002a5d5c51b#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=095081a0-1398-11dc-82e1-0002a5d5c51b#nlm34090-1"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Vascular endothelial growth factor A inhibitor","chemblIds":["CHEMBL4297163"],"targetName":"Vascular endothelial growth factor A","targetType":"single protein","targets":["ENSG00000112715"],"references":[{"source":"PubMed","ids":["14521421","12690039","14521421","10416607","14521421"],"urls":["http://europepmc.org/abstract/MED/14521421","http://europepmc.org/abstract/MED/12690039","http://europepmc.org/abstract/MED/14521421","http://europepmc.org/abstract/MED/10416607","http://europepmc.org/abstract/MED/14521421"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)","chemblIds":["CHEMBL601719"],"targetName":"NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)","targetType":"chimeric protein","targets":["ENSG00000171094","ENSG00000181163"],"references":[{"source":"FDA","ids":["label/2012/202570s003lbl.pdf","label/2012/202570s003lbl.pdf","label/2017/202570s021lbl.pdf","label/2017/202570s021lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202570s003lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202570s003lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202570s021lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202570s021lbl.pdf"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Prostanoid FP receptor agonist","chemblIds":["CHEMBL1963683"],"targetName":"Prostanoid FP receptor","targetType":"single protein","targets":["ENSG00000122420"],"references":[{"source":"FDA","ids":["label/2015/202514s003s004lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202514s003s004lbl.pdf"]}]}
{"actionType":"REDUCING AGENT","mechanismOfAction":"Cystine reducing agent","chemblIds":["CHEMBL2062263","CHEMBL602"],"references":[{"source":"DailyMed","ids":["setid=f495b76d-96c6-48e5-8fa3-30a4336628eb#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f495b76d-96c6-48e5-8fa3-30a4336628eb#nlm34090-1"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Gonadotropin-releasing hormone receptor antagonist","chemblIds":["CHEMBL2028987","CHEMBL415606"],"targetName":"Gonadotropin-releasing hormone receptor","targetType":"single protein","targets":["ENSG00000109163"],"references":[{"source":"FDA","ids":["label/2015/022201s009lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022201s009lbl.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"C-C chemokine receptor type 2 antagonist","chemblIds":["CHEMBL4457723"],"targetName":"C-C chemokine receptor type 2","targetType":"single protein","targets":["ENSG00000121807"],"references":[{"source":"PubMed","ids":["30891130"],"urls":["https://pubmed.ncbi.nlm.nih.gov/30891130/"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"G protein-coupled receptor 44 antagonist","chemblIds":["CHEMBL1914489"],"targetName":"G protein-coupled receptor 44","targetType":"single protein","targets":["ENSG00000183134"],"references":[{"source":"PubMed","ids":["23146091"],"urls":["http://europepmc.org/abstract/MED/23146091"]},{"source":"Other","ids":["http://www.ncats.nih.gov/files/AZD1981.pdf"],"urls":["http://www.ncats.nih.gov/files/AZD1981.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"C5a anaphylatoxin chemotactic receptor antagonist","chemblIds":["CHEMBL3989871"],"targetName":"C5a anaphylatoxin chemotactic receptor","targetType":"single protein","targets":["ENSG00000197405"],"references":[{"source":"PubMed","ids":["24179165"],"urls":["http://europepmc.org/abstract/MED/24179165"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Beta-2 adrenergic receptor agonist","chemblIds":["CHEMBL3989798","CHEMBL1256786"],"targetName":"Beta-2 adrenergic receptor","targetType":"single protein","targets":["ENSG00000169252"],"references":[{"source":"FDA","ids":["label/2016/022518s019,205641s005lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022518s019,205641s005lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial penicillin-binding protein inhibitor","chemblIds":["CHEMBL2303613"],"targetName":"Bacterial penicillin-binding protein","targetType":"protein family","targets":[],"references":[{"source":"PubMed","ids":["1280568","15518339","16563704","16826347","19505365"],"urls":["http://europepmc.org/abstract/MED/1280568","http://europepmc.org/abstract/MED/15518339","http://europepmc.org/abstract/MED/16563704","http://europepmc.org/abstract/MED/16826347","http://europepmc.org/abstract/MED/19505365"]}]}
